Diagnostic Haemostasis, Haematology Department, Institute of Clinical Pathology and Medical Research (ICPMR), Pathology West, Westmead Hospital, Westmead, NSW, Australia
2ECAT Foundation, Leiden, The Netherlands
3Laboratory of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, sHertogenbosch, The Netherlands
4Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
* Correspondence: E. J. Favaloro, Diagnostic Haemostasis, Haematology Department, Institute of Clinical Pathology and Medical Research (ICPMR), Pathology West, Westmead Hospital, Westmead, NSW, Australia.Tel.: +612 9845 5161 (Office/Messages), +612 9845 6618 (Laboratory); fax: +612 9689 2331;
e-mail: emmanuel.favaloro@health.nsw.gov.au
Publication HistoryIssue published online: 25 APR 2014Article first published online: 25 APR 2014Manuscript Accepted: 6 FEB 2014 SEARCH Search Scope All contentPublication titlesIn this journalIn this issue Search String Advanced >Saved Searches > SEARCH BY CITATION Volume: Issue: Page: ARTICLE TOOLSGet PDF (143K)Save to My ProfileE-mail Link to this ArticleExport Citation for this ArticleGet Citation AlertsRequest Permissions AbstractArticleReferencesCited By View Full Article (HTML) Enhanced Article (HTML) Get PDF (143K) Keywords:assay variation;diagnostic accuracy;fluorescence immunoassay;factor inhibitors;haemophilia;low titre inhibitorsSummary
Inhibitor assays are performed when patients present with unexplained prolonged routine coagulation test times and unexpected and/or unusual bleeding (potential for acquired haemophilia) as well as being a part of normal congenital haemophilia management and monitoring, particularly when bleeding occurs on therapy, or when increments in factor levels post-factor replacement remain lower than expected. In this article, we will describe the assays used, as well as their development, pitfalls in testing such as inter-laboratory variability and false negative/positive results, as well as some strategies for overcoming these pitfalls and potential alternative test approaches. The inter-laboratory coefficient of variation often approaches (and sometimes exceeds) 50%, as evidenced by various external quality assessment groups, and this variability has not improved over recent years. Additional important considerations include appropriate interpretation of test results, repeat testing for confirmation, and assessment of recovery as part of the diagnostic process.
View Full Article (HTML) Enhanced Article (HTML) Get PDF (143K) More content like this Find more content: like this article Find more content written by:E. J. FavaloroB. VerbruggenC. H. MillerAll Authors
PublicationsBrowse by SubjectResources About UsHelpContact UsAgentsAdvertisersMediaPrivacyCookiesTerms & ConditionsSite Map Copyright © 1999-2014 John Wiley & Sons, Inc. All Rights Reserved. About WileyWiley.comWiley Job Network
No comments:
Post a Comment